Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020

In the recent past, a plethora of drugs have been approved for the treatment of multiple sclerosis (MS). These therapeutics are mainly confined to immunomodulatory or immunosuppressive strategies but do not sufficiently address remyelination and neuroprotection. However, several neuroregenerative ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Huntemann, Niklas, Rolfes, Leoni, Pawlitzki, Marc, Ruck, Tobias, Pfeuffer, Steffen, Wiendl, Heinz, Meuth, Sven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217012/
https://www.ncbi.nlm.nih.gov/pubmed/34086251
http://dx.doi.org/10.1007/s40265-021-01526-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217012/
https://www.ncbi.nlm.nih.gov/pubmed/34086251
http://dx.doi.org/10.1007/s40265-021-01526-w

Ejemplares similares